{"count": 148, "results": [{"_id": "33811249", "pmid": 33811249, "pmcid": "PMC8018962", "title": "Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease", "journal": "Sci Rep", "authors": ["Grissi M", "Boudot C", "Assem M", "Candellier A", "Lando M", "Poirot-Leclercq S", "Boullier A", "Bennis Y", "Lenglet G", "Avondo C", "Lalau JD", "Choukroun G", "Massy ZA", "Kamel S", "Chillon JM", "Hénaut L"], "date": "2021-04-02T00:00:00Z", "doi": "10.1038/s41598-021-86905-9", "meta_date_publication": "2021 Apr 2", "meta_volume": "11", "meta_issue": "1", "meta_pages": "7464", "score": 50276.04, "text_hl": "$$p < 0.01, @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ vs. ", "citations": {"NLM": "Grissi M, Boudot C, Assem M, Candellier A, Lando M, Poirot-Leclercq S, Boullier A, Bennis Y, Lenglet G, Avondo C, Lalau JD, Choukroun G, Massy ZA, Kamel S, Chillon JM, Hénaut L. Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease Sci Rep. 2021 Apr 2;11(1):7464. PMID: 33811249", "BibTeX": "@article{33811249, title={Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease}, author={Grissi M and Boudot C and Assem M and Candellier A and Lando M and Poirot-Leclercq S and Boullier A and Bennis Y and Lenglet G and Avondo C and Lalau JD and Choukroun G and Massy ZA and Kamel S and Chillon JM and Hénaut L}, journal={Sci Rep}, volume={11}, number={1}, pages={7464}}"}}, {"_id": "35186553", "pmid": 35186553, "pmcid": "PMC8846262", "title": "A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin", "journal": "Cureus", "authors": ["Qureshi R", "Nasir K", "Dhrolia M", "Ahmad A"], "date": "2022-01-16T00:00:00Z", "doi": "10.7759/cureus.21291", "meta_date_publication": "2022 Jan", "meta_volume": "14", "meta_issue": "1", "meta_pages": "e21291", "score": 50275.027, "text_hl": "...In our study, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was used in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ stage 2 to 5 (not on dialysis) @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Qureshi R, Nasir K, Dhrolia M, Ahmad A. A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin Cureus. 2022 Jan;14(1):e21291. PMID: 35186553", "BibTeX": "@article{35186553, title={A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin}, author={Qureshi R and Nasir K and Dhrolia M and Ahmad A}, journal={Cureus}, volume={14}, number={1}, pages={e21291}}"}}, {"_id": "30145030", "pmid": 30145030, "title": "Metformin misuse in chronic kidney disease.", "journal": "Diabetes Metab", "authors": ["Coliche V", "Koppe L", "Laville M", "Nouvier M", "Pelletier S", "Trolliet P", "Fouque D"], "date": "2020-09-01T00:00:00Z", "doi": "10.1016/j.diabet.2018.07.005", "meta_date_publication": "2020 Sep", "meta_volume": "46", "meta_issue": "4", "meta_pages": "337-339", "score": 50274.547, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ misuse in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@.", "citations": {"NLM": "Coliche V, Koppe L, Laville M, Nouvier M, Pelletier S, Trolliet P, Fouque D. Metformin misuse in chronic kidney disease. Diabetes Metab. 2020 Sep;46(4):337-339. PMID: 30145030", "BibTeX": "@article{30145030, title={Metformin misuse in chronic kidney disease.}, author={Coliche V and Koppe L and Laville M and Nouvier M and Pelletier S and Trolliet P and Fouque D}, journal={Diabetes Metab}, volume={46}, number={4}, pages={337-339}}"}}, {"_id": "32138474", "pmid": 32138474, "pmcid": "PMC7105629", "title": "Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement", "journal": "Kidney Res Clin Pract", "authors": ["Hur KY", "Kim MK", "Ko SH", "Han M", "Lee DW", "Kwon HS", "Committee of Clinical Practice Guidelines", "Korean Diabetes Association and Committee of the Cooperative Studies", "Korean Society of Nephrology"], "date": "2020-03-31T00:00:00Z", "doi": "10.23876/j.krcp.20.012", "meta_date_publication": "2020 Mar 31", "meta_volume": "39", "meta_issue": "1", "meta_pages": "32-39", "score": 50271.996, "text_hl": "Recent recommendations on the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@", "citations": {"NLM": "Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS, Committee of Clinical Practice Guidelines, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology. Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement Kidney Res Clin Pract. 2020 Mar 31;39(1):32-39. PMID: 32138474", "BibTeX": "@article{32138474, title={Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement}, author={Hur KY and Kim MK and Ko SH and Han M and Lee DW and Kwon HS and Committee of Clinical Practice Guidelines and Korean Diabetes Association and Committee of the Cooperative Studies and Korean Society of Nephrology}, journal={Kidney Res Clin Pract}, volume={39}, number={1}, pages={32-39}}"}}, {"_id": "33126975", "pmid": 33126975, "title": "Metformin in chronic kidney disease: a strong dose of caution.", "journal": "Kidney Int", "authors": ["Hanna RM", "Rhee CM", "Kalantar-Zadeh K"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.kint.2020.04.060", "meta_date_publication": "2020 Nov", "meta_volume": "98", "meta_issue": "5", "meta_pages": "1101-1105", "score": 50269.402, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@: a strong dose of caution.", "citations": {"NLM": "Hanna RM, Rhee CM, Kalantar-Zadeh K. Metformin in chronic kidney disease: a strong dose of caution. Kidney Int. 2020 Nov;98(5):1101-1105. PMID: 33126975", "BibTeX": "@article{33126975, title={Metformin in chronic kidney disease: a strong dose of caution.}, author={Hanna RM and Rhee CM and Kalantar-Zadeh K}, journal={Kidney Int}, volume={98}, number={5}, pages={1101-1105}}"}}, {"_id": "32097995", "pmid": 32097995, "pmcid": "PMC7043977", "title": "Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement", "journal": "Diabetes Metab J", "authors": ["Hur KY", "Kim MK", "Ko SH", "Han M", "Lee DW", "Kwon HS", "Committee of Clinical Practice Guidelines, Korean Diabetes Association", "Committee of the Cooperative Studies, Korean Society of Nephrology"], "date": "2020-02-01T00:00:00Z", "doi": "10.4093/dmj.2020.0004", "meta_date_publication": "2020 Feb", "meta_volume": "44", "meta_issue": "1", "meta_pages": "3-10", "score": 50268.777, "text_hl": "Food and Drug Administration (FDA) revised @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s indication for use in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ stage 3, whereas the indications for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use set by the Korean Ministry of Food and Drug Safety remain unchanged. ", "citations": {"NLM": "Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS, Committee of Clinical Practice Guidelines, Korean Diabetes Association, Committee of the Cooperative Studies, Korean Society of Nephrology. Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement Diabetes Metab J. 2020 Feb;44(1):3-10. PMID: 32097995", "BibTeX": "@article{32097995, title={Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement}, author={Hur KY and Kim MK and Ko SH and Han M and Lee DW and Kwon HS and Committee of Clinical Practice Guidelines, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology}, journal={Diabetes Metab J}, volume={44}, number={1}, pages={3-10}}"}}, {"_id": "36313954", "pmid": 36313954, "pmcid": "PMC9559667", "title": "Lactic Acidosis Associated with Metformin in Patients with Diabetic Kidney Disease", "journal": "Med Arch", "authors": ["Rahman F", "Tuba S"], "date": "2022-08-01T00:00:00Z", "doi": "10.5455/medarh.2022.76.297-300", "meta_date_publication": "2022 Aug", "meta_volume": "76", "meta_issue": "4", "meta_pages": "297-300", "score": 50268.63, "text_hl": "In several journals explained that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ could increase @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ levels in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Rahman F, Tuba S. Lactic Acidosis Associated with Metformin in Patients with Diabetic Kidney Disease Med Arch. 2022 Aug;76(4):297-300. PMID: 36313954", "BibTeX": "@article{36313954, title={Lactic Acidosis Associated with Metformin in Patients with Diabetic Kidney Disease}, author={Rahman F and Tuba S}, journal={Med Arch}, volume={76}, number={4}, pages={297-300}}"}}, {"_id": "32622455", "pmid": 32622455, "title": "Comparison of Outcomes With Metformin and Sulfonylureas in Chronic Kidney Disease.", "journal": "Mayo Clin Proc", "authors": ["Weinrauch LA", "D'Elia JA"], "date": "2020-07-01T00:00:00Z", "doi": "10.1016/j.mayocp.2020.04.033", "meta_date_publication": "2020 Jul", "meta_volume": "95", "meta_issue": "7", "meta_pages": "1551-1552", "score": 50264.934, "text_hl": "Comparison of Outcomes With @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@Sulfonylureas@@@ in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@Chronic Kidney Disease@@@.", "citations": {"NLM": "Weinrauch LA, D'Elia JA. Comparison of Outcomes With Metformin and Sulfonylureas in Chronic Kidney Disease. Mayo Clin Proc. 2020 Jul;95(7):1551-1552. PMID: 32622455", "BibTeX": "@article{32622455, title={Comparison of Outcomes With Metformin and Sulfonylureas in Chronic Kidney Disease.}, author={Weinrauch LA and D'Elia JA}, journal={Mayo Clin Proc}, volume={95}, number={7}, pages={1551-1552}}"}}, {"_id": "39483503", "pmid": 39483503, "title": "Assessment of Metformin Intolerance: A Retrospective Chart Review.", "journal": "Innov Pharm", "authors": ["Murphy PZ", "Bramwell-Shittu A", "Boehmer K", "Painter J", "Mahashabde R"], "date": "2024-08-21T00:00:00Z", "doi": "10.24926/iip.v15i3.5779", "meta_date_publication": "2024", "meta_volume": "15", "meta_issue": "3", "meta_pages": "", "score": 50263.31, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ non-users were found to have significantly lower mean BMI (30.87 vs. 35.43; p-value <0.0001), and significantly higher rates of @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ (25.93% vs 14.73%; p-value <0.0001) as compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users. ", "citations": {"NLM": "Murphy PZ, Bramwell-Shittu A, Boehmer K, Painter J, Mahashabde R. Assessment of Metformin Intolerance: A Retrospective Chart Review. Innov Pharm. 2024;15(3):. PMID: 39483503", "BibTeX": "@article{39483503, title={Assessment of Metformin Intolerance: A Retrospective Chart Review.}, author={Murphy PZ and Bramwell-Shittu A and Boehmer K and Painter J and Mahashabde R}, journal={Innov Pharm}, volume={15}, number={3}}"}}, {"_id": "35461613", "pmid": 35461613, "title": "Metformin versus SGLT-2 inhibitors: how low can we go?", "journal": "Kidney Int", "authors": ["Pruijm M", "Phan O", "Zanchi A"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.kint.2022.02.012", "meta_date_publication": "2022 May", "meta_volume": "101", "meta_issue": "5", "meta_pages": "874-877", "score": 50262.492, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and sodium-glucose cotransporter 2 inhibitors show promise, but clinical trials with a head-to-head comparison in @SPECIES_9606 @@@patients@@@ with more advanced (stage 3b-4) @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ are largely lacking, partly for safety reasons. ", "citations": {"NLM": "Pruijm M, Phan O, Zanchi A. Metformin versus SGLT-2 inhibitors: how low can we go? Kidney Int. 2022 May;101(5):874-877. PMID: 35461613", "BibTeX": "@article{35461613, title={Metformin versus SGLT-2 inhibitors: how low can we go?}, author={Pruijm M and Phan O and Zanchi A}, journal={Kidney Int}, volume={101}, number={5}, pages={874-877}}"}}]}